AOCI at other companies
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.
The official record: Amneal Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amneal Pharmaceuticals, Inc.'s aoci.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amneal Pharmaceuticals, Inc.'s AOCI?
- Amneal Pharmaceuticals, Inc. (AMRX) reported AOCI of -$112.15M in Q1 2026.
- How has Amneal Pharmaceuticals, Inc.'s AOCI changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s AOCI decreased by 30.8% year-over-year, from -$85.74M to -$112.15M.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s AOCI?
- Over 5 years (2020 to 2025), Amneal Pharmaceuticals, Inc.'s AOCI has grown at a 21.8% compound annual growth rate (CAGR), from -$41.32M to -$110.73M.
- What does AOCI mean?
- Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.